Neuralink Begins Human Brain Implant Trials

Neuralink Opens Global Registry for Brain Implant Trials

• Neuralink, founded by Elon Musk, invites worldwide applicants with quadriplegia for brain-computer interface trials.
• The U.S. FDA approved Neuralink for human testing in September 2023; three individuals have been approved so far.
• Candidates must be at least 18 and may have conditions like quadriplegia, paraplegia, or visual impairment.
• Exclusions include those with implanted devices or a history of seizures.
• Participants will be compensated for study-related expenses.

Neuralink has opened its patient registry globally to applicants with severe disabilities, following FDA approval for human trials in September 2023. The company seeks participants aged 18 or older with specific conditions and offers compensation for related costs.